What if a patient with atrial fibrillation and anticoagulant treatment is suffering from acute ischemia stroke?

Cerebrovascular Diseases

Volumn 35, Issue 1, 2013, Pages 89-90

  Zhou, Chunkui ^a   Zhu, Lijun ^b   Wu, Jiang ^a   Fang, Shaokuan ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; TISSUE PLASMINOGEN ACTIVATOR; HEPARIN;

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; NOTE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; CASE REPORT; MALE; PROTHROMBIN TIME;

ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84875169899     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000346078     Document Type: Note

References (17)

1. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A: Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-1119.
2. Stroke Risk in Atrial Fibrillation Working Group: Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69: 546-554.
3. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D'Agostino RB: Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27: 1760-1764.
4. Kimura K, Minematsu K, Yamaguchi T: Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC). Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 6796- 6783.
5. Lin S, Wu B, Hao ZL, Kong FY, Tao WD, Wang DR, He S, Liu M: Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis 2011; 31: 419-426.
6. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
7. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E: Cardioembolic vs noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000; 10: 39- 43.
8. Benbir G, Uluduz D, Ince B, Bozluolcay M: Atherothrombotic ischemic stroke in patients with atrial fibrillation. Clin Neurol Neurosurg 2007; 109: 485-490.
9. Ogata J, Yutani C, Otsubo R, Yamanishi H, Naritomi H, Yamaguchi T, Minematsu K: Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 2008; 63: 770-781.
10. Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, May JW, Collen D: Differential sensitivity of erythrocyte-rich and plateletrich arterial thrombi to lysis with recombinant tissue type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation 1989; 79: 920-928.
11. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez- Sabín J: Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004; 35: 486-490.
12. Puig J, Pedraza S, Demchuk A, Daunis-i-Estadella J, Termes H, Blasco G, Soria G, Boada I, Remollo S, Baños J, Serena J, Castellanos M: Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2012; 33: 90-96.
13. Tsang TSM, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, Wiebers DO, Sicks J-RD, Christianson TJH, Seward JB, Gersh BJ: The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003;42: 93-100.
14. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983- 988.
15. Hart RG, Halperin JL: Atrial fibrillation and stroke: concepts and controversies. Stroke 2001;32: 803-808.
16. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the Am College of Cardiology/Am Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 2001;104: 2118-2150.
17. Marrone LC, Marrone AC: Thrombolysis in an ischemic stroke patient on Dabigatran anticoagulation: a case report. Cerebrovasc Dis 2012; 34: 246-247.